Exclusion Criteria for Depressive Disorder Trials

Depressive episodes secondary to a systemic disease or neurological disorder, such as depression due to hypothyroidism.

Received modified electric convulsive therapy (MECT), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS) or vagus nerve stimulation (VNS) within 3 months before screening.

Withdrawal of psychotropic drugs did not equate to seven half-life periods before the screening.

Women with a positive blood human chorionic gonadotropin (HCG)/urine HCG test; men with reproductive potential and women of reproductive age unable to use contraception effectively and women who plan to become pregnant within 3 months of the start of the study.

Participated in any interventional clinical trial 3 months before screening.

Free full text: Click here

Zhou J., Xu J., Liu R., Qi H., Yang J., Guo T., Zhou J., Zhu X., Zhang L., Chen X., Lyu N., Feng Z., Zhang G., Liu M., Wang W., Wang Y., Zhang Z., Xiao L., Feng Y, & Wang G. (2023). A prospective cohort study of depression (PROUD) in China: rationale and design. Current Medicine (Cham, Switzerland), 2(1), 1.

Publication 2023

Blood test Contraception Deep brain stimulation Electric convulsive therapy Human chorionic gonadotropin human Hypothyroidism Neurological disorder Psychotropic drugs Reproductive Transcranial magnetic stimulation Urine Vagus nerve stimulation Women

Corresponding Organization :

Other organizations : Beijing Anding Hospital, Capital Medical University

Top 5 similar protocols

Variable analysis

independent variables

None specified

dependent variables

None specified

control variables

Depressive episodes secondary to a systemic disease or neurological disorder, such as depression due to hypothyroidism
Received modified electric convulsive therapy (MECT), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS) or vagus nerve stimulation (VNS) within 3 months before screening
Withdrawal of psychotropic drugs did not equate to seven half-life periods before the screening
Women with a positive blood human chorionic gonadotropin (HCG)/urine HCG test; men with reproductive potential and women of reproductive age unable to use contraception effectively and women who plan to become pregnant within 3 months of the start of the study
Participated in any interventional clinical trial 3 months before screening

controls

None specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!